| 1 |
2cureX AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 2 |
2Seventy Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 3 |
3-D Matrix Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 4 |
4Basebio PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 5 |
4D Molecular Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 6 |
4Sc AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 7 |
89bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 8 |
A Science AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 9 |
Aardvark Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 10 |
AB Science SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 11 |
Abcam Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 12 |
AbCellera Biologics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 13 |
Abera Bioscience AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 14 |
Abion Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 15 |
Abionyx Pharma SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 16 |
Abivax SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 17 |
ABL Bio Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 18 |
Abliva AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 19 |
Absci Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 20 |
Acepodia Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 21 |
Achilles Therapeutics PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 22 |
Aclaris Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 23 |
Acrivon Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 24 |
Acticor Biotech SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 25 |
Actinium Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 26 |
Actinogen Medical Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 27 |
Active Biotech AB publ (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 28 |
Actuate Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 29 |
Acumen Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 30 |
Acurx Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 31 |
Adagene Inc (ADR) (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 32 |
Adagio Medical Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 33 |
Adalta Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 34 |
Adaptive Biotechnologies Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 35 |
ADC Therapeutics SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 36 |
Adial Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 37 |
Adicet Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 38 |
Aditxt Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 39 |
Adocia SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 40 |
Advagene Biopharma Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 41 |
Advanced Medical Equipment SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 42 |
Adverum Biotechnologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 43 |
Aeon Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 44 |
Affimed NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 45 |
AFYREN SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 46 |
Agalawatte Plantations PLC (Sri Lanka) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 47 |
Agile Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 48 |
Agios Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 49 |
AgResearch Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 50 |
Airway Medix SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 51 |
Akari Therapeutics PLC (ADR) (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 52 |
Akero Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 53 |
Akeso Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 54 |
Aldeyra Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 55 |
Alector Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 56 |
Algernon Health Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
5/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 57 |
Algorae Pharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 58 |
Aligos Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 59 |
Allakos Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 60 |
Allarity Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 61 |
Alligator Bioscience AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 62 |
Allogene Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 63 |
Alpha Cognition Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 64 |
Alpha IVF Group Bhd (Malaysia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
5/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 65 |
Alpha Tau Medical Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 66 |
Altamira Therapeutics Ltd (Bermuda) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 67 |
Alterola Biotech Inc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 68 |
Alvotech SA (Luxembourg) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 69 |
Alzamend Neuro Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 70 |
AlzeCure Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 71 |
Alzinova AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 72 |
Amplia Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 73 |
AN2 Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 74 |
AnaptysBio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 75 |
Anatolia TaniveBytklj Unli Ar Ge SiveTiA (Turkey) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 76 |
Anavex Life Sciences Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 77 |
Anebulo Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 78 |
AnGes Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 79 |
Angion Biomedica Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 80 |
Anhui Wanbang Pharmacutcl Tchnlgy Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 81 |
Annovis Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 82 |
Anteotech Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 83 |
Anthem BioSciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 84 |
Anti-Microbial Savior BioteQ Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 85 |
Anya Biopharm Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 86 |
AP Biosciences Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 87 |
Apimeds Pharmaceuticals US Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 88 |
Apogee Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 89 |
Applied BioCode Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 90 |
Applied Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 91 |
Aprea Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 92 |
AptaBio Therapeutics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 93 |
Aptamer Sciences Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 94 |
Aptorum Group Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 95 |
Arbutus Biopharma Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 96 |
Arcellx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 97 |
Arch Biopartners Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 98 |
Arcturus Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 99 |
Arcutis Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 100 |
Ardelyx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 101 |
Argenica Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 102 |
Argent BioPharma Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 103 |
argenx SE (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 104 |
Arovella Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 105 |
Arrivent Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 106 |
Arrowhead Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 107 |
ARS Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 108 |
Artelo Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 109 |
Arterra Bioscience SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 110 |
Artiva Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 111 |
Ascelia Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 112 |
Ascendis Pharma A/S (ADR) (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 113 |
Ascentage Pharma Group International (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 114 |
Asep Medical Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 115 |
Aspire Biopharma Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 116 |
Astria Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 117 |
ATAI Life Sciences NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 118 |
Atara Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 119 |
Atea Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 120 |
Athira Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 121 |
Aton SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 122 |
Atreca Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 123 |
aTyr Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 124 |
Aura Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 125 |
Avacta Group Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 126 |
Avalo Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 127 |
Avantium NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 128 |
Avecho Biotechnology Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 129 |
Avenue Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 130 |
Avicanna Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 131 |
Axcella Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 132 |
Axonics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 133 |
Axsome Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 134 |
Azitra Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 135 |
BACHEM HOLDING AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 136 |
Bactiquant A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 137 |
Barinthus Biotherapeutics PLC - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 138 |
Basilea Pharmaceutica AG Allschwil (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 139 |
Battelle Memorial Institute (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 140 |
BB BIOTECH AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 141 |
Beam Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 142 |
BeBetter Med Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 143 |
Beijing Northland Biotech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 144 |
Beijing Sun-Novo Pharma Research Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 145 |
Belite Bio Inc (ADR) (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 146 |
Benitec Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 147 |
BeOne Medicines AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 148 |
Bergenbio ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 149 |
Beyondspring Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 150 |
BGI Genomics Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 151 |
Bicycle Therapeutics PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 152 |
Bide Pharmatech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 153 |
Bio Meat Foodtech LP (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 154 |
Bio Path Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 155 |
Bio-Works Technologies AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 156 |
BioArctic AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 157 |
Biodexa Pharmaceuticals PLC-ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 158 |
Bioextrax AB publ (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 159 |
Biogend Therapeutics Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 160 |
BioInfra Life Science Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 161 |
BioInvent International AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 162 |
BioLASCO Taiwan Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 163 |
BioLine RX Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 164 |
BioMark Diagnostics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 165 |
Biomea Fusion Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 166 |
Biomind Labs Inc (Uruguay) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 167 |
Biomm SA (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 168 |
Biomx Inc (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 169 |
Bioneer Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 170 |
BioNexus Gene Lab Corp (Malaysia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 171 |
BioNTech SE - ADR (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 172 |
Biophytis SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 173 |
Bioqual Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 174 |
BioRestorative Therapies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 175 |
Biosergen AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 176 |
BIOTON SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 177 |
Biotron Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 178 |
Biovaxys Technology Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 179 |
Bioventix PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 180 |
BioVersys AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 181 |
Biovica International AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 182 |
BioXcel Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 183 |
bioXXmed AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 184 |
Bioxyne Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 185 |
Bivictrix Therapeutics PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 186 |
Black Diamond Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 187 |
bluebird bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 188 |
Bonus Biogroup Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 189 |
Boundless Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 190 |
BPH Energy Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 191 |
BPH Global Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 192 |
BRAIN Biotech AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 193 |
Briacell Therapeutics Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 194 |
BridgeBio Oncology Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 195 |
Bright Minds Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 196 |
BrightPath Biotherapeutics Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 197 |
Brii Biosciences Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 198 |
BRIM Biotechnology Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 199 |
BTB Korea Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 200 |
BTC Health Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 201 |
C4 Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 202 |
Cabaletta Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 203 |
Cadrenal Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 204 |
Calcimedica Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 205 |
CAMP4 Therapeutics Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 206 |
CanBas Co Ltd (Parent) (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 207 |
Candel Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 208 |
Cannabix Technologies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 209 |
Cantargia AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 210 |
Captor Therapeutics SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 211 |
Carbios SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 212 |
Carbiotix AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 213 |
Cardio Diagnostics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 214 |
Cardiol Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 215 |
CARGO Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 216 |
Caribou Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 217 |
Carisma Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 218 |
Carna Biosciences, Inc. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 219 |
Cartesian Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 220 |
Cavendish Hydrogen ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 221 |
CDT Equity Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 222 |
Celcuity Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 223 |
Cell Source Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 224 |
Cellectis SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 225 |
Cellivery Therapeutics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 226 |
CellSeed Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 227 |
Celyad Oncology SA (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 228 |
Centessa Pharmaceuticals PLC - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 229 |
Century Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 230 |
CervoMed Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 231 |
CG Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 232 |
Charles River Lbrtrs ntrntl Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 233 |
Charles River Nederland B.V. (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 234 |
Check Cap Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 235 |
Checkpoint Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 236 |
Chemomab Therapeutics Ltd - ADR (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 237 |
ChemPartner PharmaTech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 238 |
Chimerix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 239 |
China Health Group Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 240 |
Chiome Bioscience Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 241 |
Chitogenx Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 242 |
Chordia Therapeutics Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 243 |
Cibus Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 244 |
Cidara Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 245 |
Circio Holding ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 246 |
Citius Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 247 |
Cizzle Biotechnology Holdings PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 248 |
Clarity Pharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 249 |
Clearmind Medicine Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 250 |
Clearside Biomedical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 251 |
Clene Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 252 |
Clever Culture Systems Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 253 |
Climb Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 254 |
Clinuvel Pharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 255 |
Cloudbreak Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 256 |
CNS Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 257 |
Codexis Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 258 |
Cogent Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 259 |
Cognition Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 260 |
Cogstate Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 261 |
Collplant Biotechnologies Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 262 |
Collplant Biotechnologies Ltd - ADR (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 263 |
Compass Pathways PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 264 |
Compass Therapeutics Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 265 |
Connect Biopharma Holdings Ltd (ADR) (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 266 |
Context Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 267 |
Corestemchemon Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 268 |
Corvus Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 269 |
Coya Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 270 |
Creative Medical Technology Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 271 |
Crescent Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 272 |
Crescita Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 273 |
Crinetics Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 274 |
Crispr Therapeutics AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 275 |
Cronex Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 276 |
CTC Centro de Tecnologia Canavieira SA (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 277 |
Cullinan Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 278 |
Curable Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 279 |
Curacle Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 280 |
Curasight A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 281 |
CureVac BV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 282 |
Curocell Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 283 |
Cybin Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 284 |
Cyclerion Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 285 |
Cyfuse Biomedical KK (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 286 |
Cynata Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 287 |
Cyteir Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 288 |
Cytogen Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 289 |
D.Western Therapeutics Institute Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 290 |
Defence Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 291 |
Denali Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 292 |
Dermata Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 293 |
Deutsche Biotech Innovativ AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 294 |
Dextech Medical AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 295 |
Diagonal Bio AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 296 |
DiaMedica Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 297 |
Diamyd Medical AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 298 |
Dianthus Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 299 |
Dicot Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 300 |
Dimerix Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 301 |
DNA Chip Research Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 302 |
DNA Group TR Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 303 |
DND Pharmatech Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 304 |
Dogwood Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 305 |
DreamCIS Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 306 |
DV Biomed Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 307 |
Dyadic International Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 308 |
Dyne Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 309 |
e-Therapeutics plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 310 |
Eagle Filters Group Oyj (Finland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 311 |
Ecopro HN Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 312 |
Edesa Biotech Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 313 |
Edgewise Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 314 |
Editas Medicine Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 315 |
EGF Theramed Health Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 316 |
Eledon Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 317 |
Elevation Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 318 |
Emyria Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 319 |
ENCell Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 320 |
ENDRA Life Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 321 |
Energenesis Biomedical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 322 |
enGene Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 323 |
Engineering Research and Consulting, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 324 |
Enimmune Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 325 |
Enliven Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 326 |
Enlivex Therapeutics Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 327 |
Ensysce Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 328 |
Entera Bio Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 329 |
Entheon Biomedical Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 330 |
Environmental Clean Technologies Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 331 |
Eone Diagnomics Genome Center Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 332 |
Epi Biotech Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 333 |
Equillium Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 334 |
Erasca Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 335 |
Eurofins Scientific SE (Luxembourg) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 336 |
Eurofins-Cerep SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 337 |
European Institute of Science AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 338 |
Evaxion A/S (ADR) (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 339 |
Everfront Biotech Holding Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 340 |
Evogene Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 341 |
Evolus Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 342 |
EvoNext Holdings Ltd (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 343 |
Exact Sciences Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 344 |
Exact Therapeutics AS (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 345 |
Exelixis Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/4/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 346 |
Exicure Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 347 |
eXoZymes Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 348 |
Faraday Future Intelligent Electric Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 349 |
Faron Pharmaceuticals Oy (Finland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 350 |
Femtobiomed Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 351 |
FendX Technologies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 352 |
Fermentalg SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 353 |
Fibrobiologics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 354 |
FibroGen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 355 |
Finch Therapeutics Group Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 356 |
Fluicell AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 357 |
Fluoguide AS (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 358 |
Foresee Pharmaceuticals Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 359 |
Formycon AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 360 |
Forte Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 361 |
Fortrea Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 362 |
Fractyl Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 363 |
Frontage Holdings Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 364 |
Fulcrum Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 365 |
Fullhope Biomedical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 366 |
FunPep Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 367 |
Fusion Antibodies PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 368 |
Futura Medical PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 369 |
G1 Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 370 |
G2GBio Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 371 |
Gain Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 372 |
Galapagos NV (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 373 |
Galecto Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 374 |
Galera Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 375 |
Galmed Pharmaceuticals Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 376 |
GemPharmatech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 377 |
Genelux Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 378 |
Genematrix Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 379 |
Genenta Science SPA (ADR) (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 380 |
Generation Bio Co (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 381 |
Genetic Analysis AS (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 382 |
Genexine Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 383 |
GenFleet Therapeutics (Shanghai) Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 384 |
Genflow Biosciences PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 385 |
Genmab A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 386 |
Genome&Company Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 387 |
GENOMED SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 388 |
Genomics Bioscience & Technology Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 389 |
Genomictree Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 390 |
Genomtec SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 391 |
Genor Biopharma Holdings Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 392 |
genOway SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 393 |
Genprex Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 394 |
Genscript Biotech Corp (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 395 |
Gensight Biologics SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 396 |
Genus plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 397 |
Genxone SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 398 |
Geovax Labs Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 399 |
Gevo Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 400 |
GFC Green Fields Capital Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 401 |
GH Research PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 402 |
GI Innovation Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 403 |
Ginkgo Bioworks Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 404 |
GL Pharm Tech Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 405 |
Global Bioenergies SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 406 |
GlycoNex Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 407 |
Glycorex Transplantation AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 408 |
GNI Group Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 409 |
GNT Biotech & Medicals Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 410 |
GO-DX Corporation (Aust) Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 411 |
Golden Biotechnology Corp. (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 412 |
Goldenwell Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 413 |
Gongwin Biopharm Holdings Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 414 |
Gossamer Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 415 |
Grace Therapeutics, Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 416 |
GRAIL Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 417 |
Greenlight Biosciences Holdings PBC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 418 |
Greenwich Lifesciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 419 |
GRI Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 420 |
Gubra A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 421 |
Hamlet BioPharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 422 |
HanchorBio Inc (Cayman Islands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 423 |
Hangzhou Bio-sncrty Phrm-tch Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 424 |
Hangzhou Tigermed Consulting Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 425 |
Hansa Biopharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 426 |
Harvard Apparatus Regenertv Tchnlgy Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 427 |
HBL Hadasit Bio Holdings Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 428 |
Hcw Biologics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 429 |
Healios KK (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 430 |
Heartseed Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 431 |
Heidelberg Pharma AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 432 |
Helix Biopharma Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
4/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 433 |
HEM Pharma Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 434 |
Hemogenyx Pharmaceuticals PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 435 |
Hemostemix Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 436 |
Hepion Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 437 |
Herantis Pharma Oyj (Finland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 438 |
Hexima Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 439 |
Hi-Great Group Holding Co (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 440 |
HighTide Therapeutics Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 441 |
Hillevax Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 442 |
HitGen Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 443 |
HLB Pep Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 444 |
HLB Science Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 445 |
Holista Colltech Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 446 |
Hua Medicine (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 447 |
Human Metabolome Technologies Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 448 |
hVIVO PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 449 |
Hyenergy SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 450 |
Hyundai ADM Bio lnc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 451 |
Ibio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 452 |
ICON PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 453 |
IDL Diagnostics AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 454 |
IDT Australia Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 455 |
IGC Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 456 |
ImageneBio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 457 |
Imagion Biosystems Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 458 |
Imgt Corp Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 459 |
Immatics NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 460 |
Immix Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 461 |
Immuneering Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 462 |
ImmuneOncia Therapeutics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 463 |
Immunic Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 464 |
Immunitybio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 465 |
Immunotech Biopharm Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 466 |
Immunovant Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 467 |
Immunovia AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 468 |
ImmuPharma PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 469 |
Immutep Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 470 |
Imugene Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 471 |
IN8bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 472 |
Inalways Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 473 |
Incyte Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 474 |
Indaptus Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 475 |
Inflarx NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 476 |
Inhalerx Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 477 |
Inhibikase Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 478 |
Inhibitor Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 479 |
Inhibrx Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 480 |
Initiator Pharma A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 481 |
INmune Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 482 |
Innovotech Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 483 |
Inotiv Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 484 |
Inozyme Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 485 |
Instil Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 486 |
Institute of Gas Technology (d/b/a GTI Energy Corporation) (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 487 |
Intech Biopharm Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 488 |
IntegraGen SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 489 |
Intellia Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 490 |
Intelligene Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 491 |
Intensity Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 492 |
Intocell Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 493 |
Invap SE (Argentina) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 494 |
Inventionmed SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 495 |
InventisBio Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 496 |
Inventiva SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 497 |
Invex Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 498 |
Invion Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 499 |
IO Biotech Inc (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 500 |
Iovance Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 501 |
IPI Legacy Liquidation Co (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 502 |
Iqvia Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 503 |
IQVIA RDS Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 504 |
Island Pharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 505 |
ispace Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 506 |
iTeos Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 507 |
Iterum Therapeutics PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 508 |
IXICO plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 509 |
Jacobio Pharmaceuticals Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 510 |
Jade Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 511 |
Janux Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 512 |
Jasper Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 513 |
Jeevan Scientific Technology Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 514 |
Jiangsu Yahong Meditech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 515 |
Joinn Laboratories China Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 516 |
Jounce Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 517 |
JS Link Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 518 |
Jupiter Neurosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 519 |
JW (Cayman) Therapeutics Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 520 |
Jyong Biotech Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 521 |
Kadimastem Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 522 |
Kainos Medicine Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 523 |
Kairos Pharma Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 524 |
KALA BIO Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 525 |
Kalaris Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 526 |
Kalvista Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 527 |
Kang Stem Biotech Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 528 |
KBR Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/4/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 529 |
Keros Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 530 |
Kezar Life Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 531 |
Kidswell Bio Corp (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 532 |
Kineta Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 533 |
Kintor Pharmaceutical Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 534 |
Kiora Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 535 |
Kiromic Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 536 |
Klaria Pharma Holding AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 537 |
Kodiak Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 538 |
Kolon TissueGene Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 539 |
Korro Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 540 |
Kringle Pharma Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 541 |
Kronos Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 542 |
Kuros Biosciences AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 543 |
Kymera Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 544 |
Kyverna Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 545 |
Laekna Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 546 |
Lantern Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 547 |
Larimar Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 548 |
Larkberget AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 549 |
LAVA Therapeutics NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 550 |
Leap Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 551 |
Legend Biotech Corp (ADR) (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 552 |
Lenz Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 553 |
Lexeo Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 554 |
Lidds AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 555 |
LigaChem Biosciences Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 556 |
Light AI Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 557 |
Liminatus Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 558 |
Linical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 559 |
Lipella Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 560 |
Lipocine Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 561 |
Lipum AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 562 |
Liquidia Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 563 |
Lisata Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 564 |
Locus Cell Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 565 |
Longboard Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 566 |
Longeveron Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 567 |
Longevity Health Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 568 |
LTR Pharma Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 569 |
LTT Bio-Pharma Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 570 |
Lumosa Therapeutics Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 571 |
Lunai Bioworks Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 572 |
LungLife AI Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 573 |
Lyell Immunopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 574 |
Lyra Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 575 |
Lytix Biopharma AS (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 576 |
Maat Pharma SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 577 |
Mabion SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 578 |
Macrogen Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 579 |
MacroGenics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 580 |
Madrigal Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 581 |
Maia Biotechnology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 582 |
Many Bright Ideas Technologies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 583 |
Marinus Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 584 |
Matinas BioPharma Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 585 |
Matricelf Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 586 |
Mavens Biotech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 587 |
Maze Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 588 |
MBX Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 589 |
MDxHealth SA - ADR (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 590 |
Medesis Pharma SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 591 |
Medicenna Therapeutics Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 592 |
Medicofarma Biotech SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 593 |
Medicure Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 594 |
Medigen Biotechnology Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 595 |
MediGene AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 596 |
Medipost Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 597 |
Medivir AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 598 |
Medizen Humancare Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 599 |
Medlab Clinical Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 600 |
Medpace Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 601 |
Medpacto Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 602 |
MEDRx Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 603 |
Megapro Biomedical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 604 |
Mendus AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 605 |
Mersana Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 606 |
Merus NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 607 |
Mesoblast Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 608 |
MetaVia Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 609 |
Metsera Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 610 |
Microbix Biosystems Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 611 |
Microwave Chemical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 612 |
Milestone Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 613 |
Millennium Food-Tech LP (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 614 |
Mind Medicine (MindMed) Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 615 |
MindBio Therapeutics Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 616 |
Mineralys Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 617 |
Mink Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 618 |
Mira Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 619 |
MiRXES Holding Co Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 620 |
Modalis Therapeutics Corp (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 621 |
Modus Therapeutics Holding AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 622 |
Molecular Partners AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 623 |
Moleculin Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 624 |
Molecure SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 625 |
Monopar Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 626 |
Monte Rosa Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 627 |
Moogene Medi Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 628 |
Moolec Science SA (Luxembourg) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 629 |
Morphic Holding Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 630 |
MorphoSys AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 631 |
Movano Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 632 |
Mural Oncology PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 633 |
Mustang Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 634 |
Mycotopia Therapies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 635 |
Mydecine Innovations Group Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 636 |
N4 Pharma PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 637 |
Nanjing Leads Biolabs Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 638 |
Nano Mrna Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 639 |
Nanobiotix SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 640 |
Nanogroup SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 641 |
Nanotech Indonesia Global Tbk PT (Indonesia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 642 |
NanoViricides Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 643 |
Nascent Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 644 |
National Research Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 645 |
NatureCell Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 646 |
Nautilus Biotechnology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 647 |
Neoimmunetech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 648 |
Neonc Technologies Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 649 |
Neovacs SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 650 |
Neumora Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 651 |
Neuphoria Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 652 |
Neuphoria Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 653 |
Neural Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
4/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 654 |
Neurogene Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 655 |
Neuroscientific Biopharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 656 |
Neurosense Therapeutics Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 657 |
Neurotech International Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 658 |
Newron Pharmaceuticals SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 659 |
Neximmune Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 660 |
Nextage Therapeutics Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 661 |
NextCell Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
5/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 662 |
NextCure Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 663 |
Nfl Biosciences SAS (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 664 |
NGM Biopharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 665 |
Nightingale Health Oyj (Finland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 666 |
Nirvana Life Sciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 667 |
NKMax Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 668 |
NLS Pharmaceutics AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 669 |
Noile-Immune Biotech Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 670 |
Norda ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 671 |
Northwest Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 672 |
Notable Labs Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 673 |
NOUL Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 674 |
Novelstem International Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 675 |
Novomics Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 676 |
Noxopharm Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 677 |
NRX Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 678 |
NuCana PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 679 |
Numeral Ltd (Mauritius) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 680 |
Numinus Wellness Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
5/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 681 |
Nurexone Biologic Inc (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 682 |
Nuvalent Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 683 |
Nuvation Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 684 |
Nuvectis Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 685 |
Nykode Therapeutics ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 686 |
Nyrada Inc (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 687 |
OBI Pharma Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 688 |
Oculis Holding AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 689 |
OKYO Pharma Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 690 |
Olema Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 691 |
OliX Pharmaceuticals Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 692 |
OmniAB Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 693 |
OncoCross Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 694 |
Oncoinvent ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 695 |
Oncolys Biopharma Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 696 |
Onconic Therapeutics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 697 |
OncoTherapy Science, Inc. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 698 |
Onemednet Corp (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 699 |
Onesource Specialty Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 700 |
Onkure Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 701 |
Opsy Holding AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 702 |
Opthea Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 703 |
OptiBiotix Health PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 704 |
Organoidsciences Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 705 |
ORIC Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 706 |
Origin Agritech Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 707 |
Orum Therapeutics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 708 |
Oryzon Genomics SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 709 |
OS Therapies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 710 |
Ose Immunotherapeutics SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 711 |
OSR Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 712 |
Outlook Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 713 |
Ovid Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 714 |
Ovoca Bio PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 715 |
Oxford BioMedica plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 716 |
Oxurion NV (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 717 |
P3 Health Partners Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 718 |
Pacific Edge Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 719 |
Palisade Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 720 |
Pangaea Oncology SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 721 |
PanGen Biotech Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 722 |
Paradigm Biopharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 723 |
Pasithea Therapeutics Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 724 |
Passage Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 725 |
Patrys Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 726 |
PaxMedica Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 727 |
PCI Biotech Holding ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 728 |
PDS Biotechnology Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 729 |
Peak Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 730 |
Pell Bio Med Technology Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 731 |
PepGen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 732 |
Peptidream Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 733 |
Peptonic Medical AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 734 |
Percheron Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 735 |
Personalis Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 736 |
Pharma Mar SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 737 |
PharmAbcine Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 738 |
Pharmadax Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 739 |
PharmaEngine Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 740 |
PharmaResearch Bio Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 741 |
PharmaResources Shanghai Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 742 |
Pharmigene Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 743 |
Pharvaris NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 744 |
Phathom Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 745 |
Philogen SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 746 |
Phio Pharmaceuticals Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 747 |
PhoenixBio Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 748 |
Phytohealth Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 749 |
Plant Advanced Technologies PAT SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 750 |
Plantarc Bio Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 751 |
Point of Care Nano-Technology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
4/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 752 |
Polaris Group LLC (Cayman Islands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 753 |
Poltreg SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 754 |
Polyrizon Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 755 |
Pond Technologies Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 756 |
Poolbeg Pharma PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 757 |
Poseida Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 758 |
Poxel SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 759 |
PRA Health Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 760 |
Praxis Precision Medicines Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 761 |
Precision BioSciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 762 |
Predilife SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 763 |
Prelude Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 764 |
Prestige Biopharma Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 765 |
Prime Medicine Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 766 |
PRISM BioLab Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 767 |
Processa Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 768 |
ProKidney Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 769 |
Promimic AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 770 |
Promis Neurosciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 771 |
ProQR Therapeutics NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 772 |
Protagonist Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 773 |
Protara Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 774 |
Proteina Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 775 |
Proteomics International LaboratoriesLtd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 776 |
Psomagen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 777 |
Psyence Group Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 778 |
Pulmatrix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 779 |
Pure Biologics SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 780 |
Puretech Health PLC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 781 |
PYC Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 782 |
Qrons Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 783 |
Qualigen Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 784 |
Quantum BioPharma Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 785 |
Quantum Genomics SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 786 |
Quest PharmaTech Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 787 |
Quince Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 788 |
Quoin Pharmaceuticals Ltd - ADR (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 789 |
Qyuns Therapeutics Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 790 |
Race Oncology Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 791 |
Rafael Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
4/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 792 |
Rain Enhancement Technologies Holdco Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 793 |
Rain Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 794 |
Rakovina Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 795 |
Rallybio Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 796 |
Rani Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 797 |
Raphael Pharmaceutical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 798 |
Rapport Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 799 |
Rapt Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 800 |
RaQualia Pharma Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 801 |
Read Gene SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 802 |
Recursion Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 803 |
Redx Pharma PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 804 |
Regencell Bioscience Holdings Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 805 |
Regenxbio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 806 |
Regulus Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 807 |
Rein Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 808 |
RELIEF THERAPEUTICS Holding SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 809 |
Relmada Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 810 |
RenovoRx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 811 |
Repare Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 812 |
Replimune Group Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 813 |
Restart Life Sciences Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 814 |
Resverlogix Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 815 |
RetinalGenix Technologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 816 |
Revelation Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 817 |
Reviva Pharmaceuticals Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 818 |
Revive Therapeutics Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 819 |
Revolution Medicines Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 820 |
Ribomic Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 821 |
Rocket Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 822 |
Roivant Sciences Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 823 |
Rokit Healthcare Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 824 |
Rubicon Research Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 825 |
Ryvu Therapeutics SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 826 |
SAB Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 827 |
Sailong Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 828 |
Sana Biotechnology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 829 |
SanBio Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 830 |
Saniona AB (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 831 |
Sareum Holdings Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 832 |
Satellos Bioscience Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 833 |
Scancell Holdings Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
4/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 834 |
Scholar Rock Holding Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 835 |
Scinai Immunotherapeutics Ltd - ADR (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 836 |
SCM LifeScience Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 837 |
Sds Optic SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 838 |
Selvita SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 839 |
Senhwa Biosciences Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 840 |
Sensei Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 841 |
Sensorion SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 842 |
Senti Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 843 |
SenzaGen AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 844 |
Seoulin Bioscience Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 845 |
Sepura Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 846 |
Seres Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 847 |
Sernova Biotherapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 848 |
Serodus AS (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 849 |
Shanghai Aladdin Biochemical Tech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 850 |
Shanghai Medicilon Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 851 |
Shanxi Jinbo Bio-pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 852 |
Shaperon Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 853 |
Sharp Therapeutics Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 854 |
Shattuck Labs Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 855 |
Shin Nippon Biomedical Laboratories Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 856 |
Shine-On BioMedical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 857 |
Shortwave Life Sciences PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 858 |
Shouyao Holdings Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 859 |
Shree Ganesh Remedies Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 860 |
Shuttle Pharmaceuticals Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 861 |
Sichuan Kelun-Biotech Biophrmctcl Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 862 |
Silence Therapeutics plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 863 |
Silexion Therapeutics Corp (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 864 |
SillaJen Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 865 |
SINEW Pharma Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 866 |
Sino Biological Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 867 |
Sinocelltech Group Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 868 |
Sionna Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 869 |
Sirona Biochem Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 870 |
Skinbiotherapeutics PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 871 |
Skye Bioscience Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 872 |
Sofiva Genomics Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 873 |
Sol Gel Technologies Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 874 |
Solar Foods Oyj (Finland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 875 |
Solarvest Bioenergy Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
4/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 876 |
Soleno Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 877 |
Sona Nanotech Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 878 |
Sonnet Biotherapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 879 |
Spago Nanomedical AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 880 |
Spero Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 881 |
Spirit Scientific Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 882 |
SpringWorks Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 883 |
Sprint Bioscience AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 884 |
Spruce Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 885 |
Spyre Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 886 |
SS Innovations International Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 887 |
StageZero Life Sciences Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 888 |
Starpharma Holdings Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 889 |
Stayble Therapeutics AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 890 |
Steakholder Foods Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 891 |
Stem Cells Spin SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 892 |
StemCyte International Ltd (Cayman Islands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 893 |
Steminent Biotherapeutics Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 894 |
StimCell Enegetics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 895 |
Stoke Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 896 |
Storage Drop Storage Technologies Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 897 |
Strategic Partners A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 898 |
Structure Therapeutics Inc (ADR) (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 899 |
Sun Pharma Advanced Research Co Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 900 |
Sunhawk Vision Biotech Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 901 |
Sunho Biologics Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 902 |
Sunmax Biotechnology Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 903 |
Suven Life Sciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 904 |
Sygnis SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 905 |
Synairgen plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 906 |
Syndax Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 907 |
Syneos Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 908 |
SyneuRx International Taiwan Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 909 |
Syngene International Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 910 |
Synlogic Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 911 |
Syntara Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 912 |
SyntheticMR AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 913 |
Syros Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 914 |
TaiGen Biopharmaceuticals Holdings Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 915 |
TaiMed Biologics Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 916 |
TaiRx Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 917 |
Taiwan Bio Therapeutics Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 918 |
TaiwanJ Pharmaceuticals Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 919 |
Takara Bio Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 920 |
Take Solutions Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 921 |
Talis Biomedical Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 922 |
Talisker Resources Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 923 |
Tango Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 924 |
Tanvex Biopharma Inc (Cayman Islands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 925 |
Taysha Gene Therapies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 926 |
TC Biopharm (Holdings) PLC - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 927 |
Tectonic Therapeutic Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 928 |
Telix Pharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 929 |
Telo Genomics Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 930 |
Tempest Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 931 |
Tenax Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 932 |
Tenaya Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 933 |
Terns Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 934 |
Terragen Holdings Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 935 |
Tetratherix Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 936 |
TFF Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 937 |
Tharimmune Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 938 |
TheraCryf PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 939 |
Theranexus SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 940 |
Therapeutic Solutions International Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 941 |
Therma Bright Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
4/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 942 |
Thiogenesis Therapeutics Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 943 |
Thor Medical ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 944 |
TiumBio Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 945 |
Tiziana Life Sciences Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 946 |
Tiziana Life Sciences Ltd - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 947 |
TME Pharma NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 948 |
TMS Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 949 |
Toleranzia AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 950 |
Tonix Pharmaceuticals Holding Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 951 |
ToolGen Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 952 |
Tourmaline Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 953 |
TRACON Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 954 |
Transcode Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 955 |
Transgene Biotek Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 956 |
TransThera Sciences (Nanjing) Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 957 |
Traws Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 958 |
Trevena Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 959 |
Trevi Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 960 |
Tryptamine Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 961 |
Tsubota Laboratory Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 962 |
TuHURA Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 963 |
Tvardi Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 964 |
Twi Biotechnology Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 965 |
TYK Medicines Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 966 |
Tyra Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 967 |
Ulisse Biomed Spa (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 968 |
Unicocell Biomed Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 969 |
Unicycive Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 970 |
Uniqure NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 971 |
Unity Biotechnology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 972 |
Urogen Pharma Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 973 |
Urteste SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 974 |
Vaccinex Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 975 |
Valbiotis SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 976 |
ValiRx Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 977 |
Vanta Bioscience Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 978 |
Vaxcyte Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 979 |
Vaxil Bio Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 980 |
Vectus Biosystems Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 981 |
Verastem Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 982 |
Veritas In Silico Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 983 |
Veru Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 984 |
Verve Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 985 |
Vicarious Surgical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 986 |
ViGenCell Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 987 |
Vigil Neuroscience Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 988 |
Viking Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 989 |
Vimta Labs Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 990 |
Vir Biotechnology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 991 |
ViroGates A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 992 |
Virpax Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 993 |
Visen Pharmaceuticals (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 994 |
Vistagen Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 995 |
VIVA Biotech Holdings (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 996 |
Vivakor inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 997 |
Vivo Bio Tech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 998 |
Vivoryon Therapeutics NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 999 |
VolitionRX Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,000 |
Vor Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,001 |
Voyager Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,002 |
vTv Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,003 |
Vyne Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,004 |
Vyome Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,005 |
Vytrus Biotech SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,006 |
Wave Life Sciences Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,007 |
Waverley Pharma Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,008 |
Welgene Biotech Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,009 |
Wilk Technologies Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,010 |
WuXi AppTec Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,011 |
X T L Biopharmaceuticals Ltd (ADR) (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,012 |
XBiotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,013 |
Xbrane Biopharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,014 |
Xencor Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,015 |
Xenon Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,016 |
Xilio Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,017 |
Xinjiang Bai Hua Cun Pharma Tech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,018 |
Xintela AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,019 |
XSpray Pharma AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,020 |
XtalPi Holdings Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,021 |
Y Biologics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,022 |
YD Bio Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,023 |
Yield10 Bioscience Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,024 |
Yubo International Biotech Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,025 |
Zealand Pharma A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,026 |
Zelira Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,027 |
Zenas Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,028 |
Zentalis Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,029 |
Zentek Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,030 |
Zevra Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,031 |
Zura Bio Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,032 |
Zymeworks Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,033 |
ZYUS Life Sciences Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |